We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 43.61%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+43.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.52B
AUM Growth
+$61.3M
Cap. Flow
-$261M
Cap. Flow %
-7.42%
Top 10 Hldgs %
30.27%
Holding
462
New
43
Increased
110
Reduced
173
Closed
35

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$40.3M
2
AAP icon
Advance Auto Parts
AAP
+$37.7M
3
AGN
Allergan plc
AGN
+$32.5M
4
NSC icon
Norfolk Southern
NSC
+$32.3M
5
ORLY icon
O'Reilly Automotive
ORLY
+$30.5M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$71.8M
2
META icon
Meta Platforms (Facebook)
META
+$67.6M
3
IDXX icon
Idexx Laboratories
IDXX
+$46.2M
4
TTWO icon
Take-Two Interactive
TTWO
+$43.2M
5
DPZ icon
Domino's
DPZ
+$37.6M

Sector Composition

Rank Sector Weight
1 Technology 30.23%
2 Consumer Discretionary 15.27%
3 Healthcare 14.62%
4 Industrials 13.42%
5 Financials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
226
Heron Therapeutics
HRTX
$85.7M
$282K 0.01%
+8,910
New +$332K
RGEN icon
227
Repligen
RGEN
$8.61B
$281K 0.01%
5,058
+400
+9% +$20.6K
MOV icon
228
Movado Group
MOV
$849M
$280K 0.01%
6,684
– –
THFF icon
229
First Financial Corp
THFF
$939M
$280K 0.01%
5,576
– –
RDNT icon
230
RadNet
RDNT
$4.85B
$276K 0.01%
18,358
– –
JOUT icon
231
Johnson Outdoors
JOUT
$503M
$275K 0.01%
2,955
– –
RGNX icon
232
Regenxbio
RGNX
$596M
$275K 0.01%
+3,640
New +$262K
VVX icon
233
V2X
VVX
$2.81B
$274K 0.01%
8,793
-24,260
-73% -$782K
LNTH icon
234
Lantheus
LNTH
$6.59B
$265K 0.01%
17,737
– –
FOLD
235
DELISTED
Amicus Therapeutics
FOLD
$264K 0.01%
21,860
+890
+4% +$12.4K
AROW icon
236
Arrow Financial
AROW
$663M
$261K 0.01%
8,174
– –
ARNA
237
DELISTED
Arena Pharmaceuticals Inc
ARNA
$256K 0.01%
5,570
-110
-2% -$4.46K
APEI icon
238
American Public Education
APEI
$918M
$250K 0.01%
7,576
– –
SYBT icon
239
Stock Yards Bancorp
SYBT
$2.47B
$250K 0.01%
6,895
– –
ANGO icon
240
AngioDynamics
ANGO
$589M
$236K 0.01%
10,871
– –
CASH icon
241
Pathward Financial
CASH
$1.84B
$232K 0.01%
8,406
– –
TPCO
242
DELISTED
Tribune Publishing Company Common Stock
TPCO
$230K 0.01%
14,088
– –
NVMI
243
Nova
NVMI
$12.7B
$229K 0.01%
8,694
– –
OSUR icon
244
OraSure Technologies
OSUR
$273M
$229K 0.01%
14,851
– –
GSBC icon
245
Great Southern Bancorp
GSBC
$873M
$216K 0.01%
3,894
– –
PTLA
246
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$216K 0.01%
8,100
+2,740
+51% +$89.5K
ONCE
247
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$215K 0.01%
3,950
+1,120
+40% +$76.6K
DX
248
Dynex Capital
DX
$3.01B
$207K 0.01%
10,818
– –
SPPI
249
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$199K 0.01%
+11,840
New +$256K
QCRH icon
250
QCR Holdings
QCRH
$1.66B
$189K 0.01%
4,638
– –
8 9
10
11 12

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return

Smith Group Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Smith Group Asset Management held 462 positions worth $3.52B, up 1.8% from $3.46B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Smith Group Asset Management withdrew a net $261M in Q3 2018, closing 35 positions and reducing 173 holdings. Its most notable exit was Idexx Laboratories, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Smith Group Asset Management opened a new position in Bristol-Myers Squibb worth $42.1M.

  • Smith Group Asset Management's largest Q3 2018 buy was Bristol-Myers Squibb: 678,557 shares worth $42.1M.
  • Smith Group Asset Management added most to Automatic Data Processing in Q3 2018, an estimated $30.5M increase.
  • Smith Group Asset Management's biggest Q3 2018 reduction was McDonald's, cutting an estimated $71.8M.
  • Smith Group Asset Management fully exited Idexx Laboratories in Q3 2018, selling an estimated $46.2M.
  • Smith Group Asset Management's ten largest holdings make up 30% of its $3.52B portfolio in Q3 2018.
  • Smith Group Asset Management opened 43 new positions and closed 35 in Q3 2018.
  • Smith Group Asset Management's portfolio value rose 1.8% quarter-over-quarter to $3.52B.

Based on Smith Group Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.